Search Results

YM-90709 2 mg  | 99.67%

TargetMol

YM-90709 is a new-type antagonist inhibiting the binding of interleukin-5 to the interleukin-5 receptor.

More Information Supplier Page

Ruxolitinib phosphate 25 mg  | 99.86%

TargetMol

Ruxolitinib phosphate(INCB018424 phosphate) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3.

More Information Supplier Page

(-)-Huperzine A 25 mg  | 99.73%

TargetMol

Huperzine A, an active Lycopodium alkaloid extracted from the traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer’s disease (AD).

More Information Supplier Page

KM11060 5 mg  | 99.67%

TargetMol

KM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma membrane.

More Information Supplier Page

KM11060 25 mg  | 99.67%

TargetMol

KM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma membrane.

More Information Supplier Page